首页> 外国专利> PREVENTING AND/OR TREATING AGENT OF DISEASE CAUSED BY ADIPONECTINE CONCENTRATION DECREASE AND/OR C-REACTIVE PROTEIN CONCENTRATION INCREASE AND/OR IL-18 CONCENTRATION INCREASE

PREVENTING AND/OR TREATING AGENT OF DISEASE CAUSED BY ADIPONECTINE CONCENTRATION DECREASE AND/OR C-REACTIVE PROTEIN CONCENTRATION INCREASE AND/OR IL-18 CONCENTRATION INCREASE

机译:预防和/或治疗由脱氧核糖核酸浓度降低和/或C阳性蛋白浓度升高和/或IL-18浓度升高引起的疾病

摘要

PROBLEM TO BE SOLVED: To obtain a medicine for preventing and/or treating diseases caused by the decrease in the concentration of adiponectine and/or increase in the concentration of C-reactive protein and/or increase in the concentration of IL-18.;SOLUTION: This preventing and/or treating agent of diseases caused by the decrease in the concentration of adiponectine and/or increase in the concentration of C-reactive protein and/or increase in the concentration of IL-18 contains a substance selected from the group consisting of an aminoalkoxybibenzyl expressed by formula (2), its pharmacologically acceptable salts, esters, and their solvates and hydrates as an active ingredient.;COPYRIGHT: (C)2005,JPO&NCIPI
机译:要解决的问题:获得一种用于预防和/或治疗由脂联素浓度降低和/或C反应蛋白浓度升高和/或IL-18浓度升高引起的疾病的药物。解决方案:这种由脂联素浓度降低和/或C反应蛋白浓度升高和/或IL-18浓度升高引起的疾病的预防和/或治疗药物包含选自以下物质:由式(2)表示的氨基烷氧基联苄基,其药学上可接受的盐,酯及其溶剂化物和水合物作为有效成分组成;版权所有:(C)2005,JPO&NCIPI

著录项

  • 公开/公告号JP2005053890A

    专利类型

  • 公开/公告日2005-03-03

    原文格式PDF

  • 申请/专利权人 MITSUBISHI PHARMA CORP;

    申请/专利号JP20040020645

  • 发明设计人 KANDA TSUGIYASU;YAMAKAWA JUNICHI;

    申请日2004-01-29

  • 分类号A61K31/138;A61K31/195;A61K31/225;A61K31/445;A61K31/4453;A61P9/10;A61P43/00;

  • 国家 JP

  • 入库时间 2022-08-21 22:30:13

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号